Hiroki Osumi

Paradigm Shifts in Perioperative Management of Colorectal Cancer: Personalization Based on Tumor Biology, Primary Site, and Recurrence Risk, and the Evolving Role of Organ Preservation

Kaoru Yoshikawa, Akira Ooki, Eiji Shinozaki, Eiichiro Toyokawa et autres

jp (code pays fourni par la source)

Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer

Hiroki Osumi, Eiji Shinozaki, Yoshiaki Nakamura, Taito Esaki et autres

jp (code pays fourni par la source)

Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4)

Keita Tashiro, Hiroki Osumi, Kozo Kataoka, Yasuhiro Shimada et autres

jp, us (code pays fourni par la source)

Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

Keitaro Shimozaki, Akira Ooki, Shota Fukuoka, Hiroki Osumi et autres

jp (code pays fourni par la source)

Table S2 from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi et autres

Table S1 from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi et autres

Table S4 from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi et autres

Figure S1 from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi et autres

Table S3 from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi et autres

Data from ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda, Senzo Taguchi et autres

Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort

Yuka Morita, Koichi Takeda, Hiroki Osumi, Yosuke Aoyama et autres

jp (code pays fourni par la source)

Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC

Kazuo Kobayashi, Takeru Wakatsuki, Erika Sugiyama, Eiji Shinozaki et autres

jp (code pays fourni par la source)